← feed

Is NCT03155503 results overdue?

Yes — results are overdue. Primary completion was 2018-03-07; the FDAAA-801 reporting deadline (2019-03-07) passed 2709 days ago and no results are posted on ClinicalTrials.gov.

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-911 in Healthy Subjects

NCT IDNCT03155503 ↗
SponsorSuven Life Sciences Limited (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2018-03-07 (ACTUAL)
Reporting deadline2019-03-07 (completion + 365d)
Days overdue2709
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 f16a7a3d08b6366c… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03155503. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →